(Press-News.org) Higher rates of Autism Spectrum Disorders in males than females may be related to changes in the brain's estrogen signalling, according to research published in the open access journal Molecular Autism.
The study examined the brains of people that had Autism Spectrum Disorders compared to controls, and found that they are linked with far lower levels of a key estrogen receptor and other estrogen-related proteins. Because of the small group size, these results indicate an exciting avenue for further research, rather than confirming a role for altered estrogen signalling in Autism Spectrum Disorders.
Anilkumar Pillai, lead author, says: "Our study is the first indicator that estrogen receptors in the brain of Autism Spectrum Disorder patients may be different to controls. Though this suggests a possible reason for the gender bias, we still need to determine what causes the reduced production of estrogen-related proteins."
Autism Spectrum Disorders are a group of disorders that affect brain development, and are commonly recognized by impaired social interaction, verbal and non-verbal communication, and restricted and repetitive behavior. The disorders appear to have a genetic basis and are around four times more common in men than in women. Autism Spectrum Disorders have been associated with higher levels of the sex hormone testosterone, but whether there is a relationship between the disorders and estrogen signalling was not known.
A group of researchers from Georgia Regents University measured the expression of proteins involved in the estrogen signalling pathway in brain tissue from 13 people that had Autism Spectrum Disorders and 13 controls. The low numbers involved in the study are because brain tissue for experimental use from individuals that had Autism spectrum Disorders is quite scarce. They looked for levels of ERβ - an estrogen receptor molecule, and aromatase, an enzyme which converts testosterone to estradiol, the most potent estrogen.
They found 35% less ERβ mRNA and 38% less aromatase mRNA in autistic brain tissue in comparison with controls. They also found much less of the mRNA of estrogen receptor co-factors SRC1, CBP and P/CAF - 34%, 77% and 52% respectively. The lower levels of estrogen receptors and aromatase could lead to reduced conversion of testosterone to estradiol, resulting in increased levels of testosterone.
Anilkumar Pillai says "It is worth looking at whether drugs which modulate estrogen reception, but do not cause feminization, could allow for the long-term treatment of male patients with Autism Spectrum Disorders. Current treatment involves the use of antipsychotics, which has long been a major concern as these patients are typically still in a stage of life where brain development is very rapid. However, additional studies are needed to test the estrogen mechanism."
INFORMATION:
Media Contact
Shane Canning
Media Officer
BioMed Central
T: +44 (0)20 3192 2243
E: shane.canningn@biomedcentral.com
Notes to Editor
1. Research
Dysregulation of Estrogen Receptor beta (ERbeta), Aromatase (CYP19A1) and ER Co-activators in the middle frontal gyrus of autism spectrum disorder subjects
Amanda Crider, Roshni Thakkar, Anthony o Ahmed and Anilkumar Pillai
Molecular Autism 2014, 5: 46. doi:10.1186/2040-2392-5-46
For a copy of the paper during embargo please contact Shane Canning
After embargo, article available at journal website here:
http://www.molecularautism.com/content/5/1/46
Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.
2. Molecular Autism is a peer-reviewed, online open access journal that publishes high-quality basic, translational and clinical research that has relevance to the etiology, pathobiology, or treatment of autism and related neurodevelopmental conditions. Research that includes integration across levels is encouraged. Molecular Autism publishes empirical studies, reviews, and brief communications.
3. BioMed Central is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.
Sex hormones may play a part in autism
2014-09-09
ELSE PRESS RELEASES FROM THIS DATE:
Interactive dark matter could explain Milky Way's missing satellite galaxies
2014-09-09
Scientists believe they have found a way to explain why there are not as many galaxies orbiting the Milky Way as expected.
Computer simulations of the formation of our galaxy suggest that there should be many more, smaller galaxies around the Milky Way than are observed through telescopes.
This has thrown doubt on the generally accepted theory of cold dark matter, a substance that scientists predict should allow for more galaxy formation around the Milky Way than is seen.
Now cosmologists and particle physicists at the Institute for Computational Cosmology (ICC) and ...
Study finds tear gas could have temporary impact on lung health
2014-09-09
Munich, Germany: The effects of tear gas are not just short term and could be experienced for up to two weeks after the event, according to a new study.
The study, presented at the European Respiratory Society (ERS) International Congress in Munich today (10 September 2014), investigated the duration of lung health effects in protesters directly exposed to tear gas.
Researchers in Turkey conducted a questionnaire survey with 546 people who had inhaled tear gas during public protests in June 2013. They collected information on smoking history, exposure to tear gas, ...
Fish oil may help curb seizure frequency in epilepsy
2014-09-09
But high doses were no better than dummy (placebo treatment), the findings indicated.
The omega-3 fatty acids found in fish oil are able to cross over from the bloodstream into heart cells where they work to stabilise heart rhythm and protect against heart attacks.
This is particularly important for people with epilepsy because they have a significantly higher risk of having a heart attack than those without the condition.
And experimental research indicates that omega 3 fatty acids can also cross over into the central nervous system, where they reduce the excitability ...
Study of almost 900,000 people shows prediabetes increases the risk of cancer by 15 percent
2014-09-09
A meta-analysis comprising 16 studies and 891,426 participants from various regions of the world shows that prediabetes increases the risk of cancer by 15%, with differing risks depending on the type of cancer. The study, published in Diabetologia (the journal of the European Association for the Study of Diabetes) is by Professor Yuli Huang, The First People's Hospital of Shunde, Daliang Town, Shunde District, China, and colleagues.
Prediabetes is a general term that refers to an intermediate stage between normoglycaemia and overt diabetes mellitus. It includes individuals ...
E-cigarette nicotine refill cartridges pose danger for toddlers
2014-09-09
The safety of nicotine refill cartridges used in electronic cigarettes needs to be improved to prevent toddlers accidentally swallowing the contents and potentially coming to serious harm, warn doctors in Archives of Disease in Childhood.
The warning follows their treatment of a suspected case in the UK and emerging US data on the substantial rise of unintentional nicotine poisoning from e-cigarettes among the under 5s.
The UK toddler was brought into the emergency care department of Good Hope Hospital in Birmingham after the child's mother had spotted her picking up ...
The Lancet Respiratory Medicine: Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial)
2014-09-09
This study of 1358 children investigated whether intermittent montelukast (a drug widely used to treat wheeze and other asthmatic symptoms) compared with placebo, reduced wheezing episodes in children aged 10 months to 5 years, and whether patient outcome differed according to genotype. Study authors found that intermittent montelukast only reduced wheezing episodes in children with arachidonate 5-lipoxygenase (ALOX5) gene promoter 5/5, a gene that has previously been associated with a better response to montelukast in adults. There was no correlation with reduced wheezing ...
Tip sheet from Annals of Internal Medicine, Sept. 9, 2014
2014-09-09
1. Health insurance not affordable for many under Affordable Care Act
For many younger adults, the penalty for not buying health insurance may be less than the price of the least expensive plan available under the Patient Protection and Affordable Care Act (ACA), according to a study being published in Annals of Internal Medicine. The ACA aims to expand health care coverage in part by providing subsidies to individuals with low annual incomes. The law mandates that individuals purchase health insurance or pay a penalty. The penalty is waived if the cost of the least-expensive ...
Should lung cancer screening be covered for Medicare beneficiaries?
2014-09-09
1. Should lung cancer screening be covered for Medicare beneficiaries?
Experts analyze evidence from the National Lung Screening Trial
Researchers for the Centers for Medicare and Medicaid Services (CMS) analyze evidence on the benefits and harms of lung cancer screening by age in a study being published in Annals of Internal Medicine. Smoking is the most important risk factor for developing lung cancer. The National Lung Screening Trial (NLST) reported a reduction in lung cancer mortality in high-risk participants aged 55 to 74 who were randomly assigned to screening ...
September/October 2014 Annals of Family Medicine Tip Sheet
2014-09-09
Illinois' Medicaid Primary Care Case Management Program Associated With Substantial Savings, Reductions in Inpatient and Emergency Care and Improvements in Quality Measures
Illinois was an early leader in comprehensive Medicaid reform, implementing a primary care case management program, Illinois Health Connect, and a complementary disease management program, Your Healthcare Plus, in 2006. The programs aimed to promote preventive care, reduce the redundancy of services through continuity of care with a primary care provider, and improve the management of chronic diseases. ...
Researchers improve severe asthma care through new, antibody-based treatment
2014-09-09
September 8, 2014 – Hamilton, ON – A team of researchers at McMaster University and St. Joseph's Healthcare Hamilton have successfully evaluated a new, antibody-based drug for certain patients with severe asthma. The drug – named mepolizumab – can replace traditional, steroid-based treatments for a specific subset of patients, resulting in improved outcomes and reduced side effects.
The study and manuscript, published in the New England Journal of Medicine was led in Canada by Dr. Parameswaran Nair, staff respirologist, Firestone Institute for Respiratory Health at ...